Human Genome Epidemiology Literature Finder
|
Records 1 - 30 (of 67 Records) |
| Query Trace: Breast Neoplasms and MS[original query] |
|---|
| Role of the UGT2B17 deletion in exemestane pharmacogenetics. The pharmacogenomics journal 2017 May . Luo S, Chen G, Truica C, Baird C C, Leitzel K, Lazarus |
| Attempted replication of SNPs in RANKL and OPG with musculoskeletal adverse events during aromatase inhibitor treatment for breast cancer. Physiological genomics 2017 Dec physiolgenomics.00085.2017. Dempsey Jacqueline M, Xi Jingyue, Henry N Lynn, Rae James M, Hertz Daniel |
| Association between UDP-glucuronosyltransferase 2B7 tagSNPs and breast cancer risk in Chinese females. Clinical and experimental pharmacology & physiology 2018 05 45 (5): 437-443. He Bao-Xia, Qiao Bin, Lam Alfred King-Yin, Zhao Xiu-Li, Zhang Wen-Zhou, Liu H |
| Significant alterations of the novel 15 gene signature identified from macrophage-tumor interactions in breast cancer. Biochimica et biophysica acta. General subjects 2017 12 1862 (3): 669-683. Singh Rajshri, Dagar Priya, Pal Shyama, Basu Bhakti, Shankar Bhavani |
| Promoter Methylation of BRCA1, DAPK1 and RASSF1A is Associated with Increased Mortality among Indian Women with Breast Cancer. Asian Pacific journal of cancer prevention : APJCP 2018 2 19 (2): 443-448. Yadav Prasant, Masroor Mirza, Nandi Kajal, Kaza R C M, Jain S K, Khurana Nita, Saxena Alpa |
| CYP2D6 Genotype Predicts Plasma Concentrations of Tamoxifen Metabolites in Ethiopian Breast Cancer Patients. Cancers 2019 9 11 (9): . Ahmed Jemal Hussien, Makonnen Eyasu, Fotoohi Alan, Aseffa Abraham, Howe Rawleigh, Aklillu Ele |
| Parkin gene mutations are not common, but its epigenetic inactivation is a frequent event and predicts poor survival in advanced breast cancer patients. BMC cancer 2019 Aug 19 (1): 820. Wahabi Khushnuma, Perwez Ahmad, Kamarudheen Shabeena, Bhat Zafar Iqbal, Mehta Anurag, Rizvi M Moshahid |
| Clinical Trial: CYP2D6 Related Dose Escalation of Tamoxifen in Breast Cancer Patients With Iranian Ethnic Background Resulted in Increased Concentrations of Tamoxifen and Its Metabolites. Frontiers in pharmacology 2019 6 10 530. Khalaj Zahra, Baratieh Zohreh, Nikpour Parvaneh, Schwab Matthias, Schaeffeler Elke, Mokarian Fariborz, Khanahmad Hossein, Salehi Rasoul, Mürdter Thomas E, Salehi Manso |
| Prognostic impact of genetic variants of CYP19A1 and UGT2B17 in a randomized trial for endocrine-responsive postmenopausal breast cancer. The pharmacogenomics journal 2019 Apr . Johansson Harriet, Aristarco Valentina, Gandini Sara, Gjerde Jennifer, Macis Debora, Guerrieri-Gonzaga Aliana, Serrano Davide, Lazzeroni Matteo, Rajasekaran Agnita, Williard Clark V, Mellgren Gunnar, DeCensi Andrea, Bonanni Bernar |
| ABCC2 c.-24 C>T single-nucleotide polymorphism was associated with the pharmacokinetic variability of deferasirox in Chinese subjects. European journal of clinical pharmacology 2019 Nov . Cao Kangna, Ren Guanghui, Lu Chengcan, Wang Yao, Tan Yanan, Zhou Jing, Zhang Yongjie, Lu Yang, Li Ning, Chen Xijing, Zhao |
| Association of CYP19A1 gene variations with adjuvant letrozole-induced adverse events in South Indian postmenopausal breast cancer cohort expressing hormone-receptor positivity. Breast cancer research and treatment 2020 May . Umamaheswaran Gurusamy, Kadambari Dharanipragada, Muthuvel Suresh Kumar, Kalaivani Sekar, Devi Jaganathan, Damodaran Solai Elango, Pradhan Suresh Chandra, Dubashi Biswajit, Dkhar Steven Aibor, Adithan Chandrasekar |
| Genetic Variability in the microRNA Binding Sites of BMPR1B, TGFBR1, IQGAP1, KRAS, SETD8 and RYR3 and Risk of Breast Cancer in Colombian Women. OncoTargets and therapy 2020 13 12281-12287. Garcia Mesa Karen, Bermejo Justo Lorenzo, Torres Diana, Gilbert Michael, Plass Christoph, Hamann U |
| Association of plasma docetaxel levels with ABCB1 gene polymorphisms and tumour response in locally advanced breast cancer patients of South India on neo-adjuvant chemotherapy. Breast cancer (Tokyo, Japan) 2020 10 28 (2): 414-423. Priyadarshini Rekha, Raj Gerard Marshall, Sundaram Rajan, Kayal Smita, Ramesh Ananthakrishnan, Shewade Deepak Gop |
Genome-wide association study of letrozole plasma concentrations identifies non-exonic variants that may affect CYP2A6 metabolic activity.
Pharmacogenetics and genomics 2021 Jul 31 (5): 116-123. Hertz Daniel L, Douglas Julie A, Kidwell Kelley M, Gersch Christina L, Desta Zeruesenay, Storniolo Ana-Maria, Stearns Vered, Skaar Todd C, Hayes Daniel F, Henry N Lynn, Rae James |
| Clinical utility of testing for PALB2 and CHEK2 c.1100delC in breast and ovarian cancer. Genetics in medicine : official journal of the American College of Medical Genetics 2021 Jun . Woodward Emma R, van Veen Elke M, Forde Claire, Harkness Elaine F, Byers Helen J, Ellingford Jamie M, Burghel George J, Schlech Helene, Bowers Naomi L, Wallace Andrew J, Howell Sacha J, Howell Anthony, Lalloo Fiona, Newman William G, Smith Miriam J, Gareth Evans |
| Polymorphisms of T- cell leukemia 1A gene loci are not related to the development of adjuvant letrozole-induced adverse events in breast cancer. PloS one 2021 16 (3): e0247989. Umamaheswaran Gurusamy, Kadambari Dharanipragada, Muthuvel Suresh Kumar, Kumar Naveena A N, Dubashi Biswajit, Aibor Dkhar Steven, Adithan Chandrasekar |
| An Integrated Pharmacological Counselling Approach to Guide Decision-Making in the Treatment with CDK4/6 Inhibitors for Metastatic Breast Cancer. Frontiers in pharmacology 2022 8 13 897951. Roncato Rossana, Gerratana Lorenzo, Palmero Lorenza, Gagno Sara, Poetto Ariana Soledad, Peruzzi Elena, Zanchetta Martina, Posocco Bianca, De Mattia Elena, Canil Giovanni, Alberti Martina, Orleni Marco, Toffoli Giuseppe, Puglisi Fabio, Cecchin Eri |
| Urinary concentration of endocrine-disrupting phthalates and breast cancer risk in Indian women: A case-control study with a focus on mutations in phthalate-responsive genes. Cancer epidemiology 2022 6 79 102188. Mukherjee Das Ankan, Gogia Ajay, Garg Manoj, Elaiyaraja Arun, Arambam Priyadarshini, Mathur Sandeep, Babu-Rajendran Ramaswamy, Deo S V S, Kumar Lalit, Das Bhudev C, Janardhanan Raj |
| Prevalence of type 2 diabetes mellitus in relation to arsenic exposure and metabolism in Mexican women. Environmental research 2022 Feb 210 112948. Rangel-Moreno Karla, Gamboa-Loira Brenda, López-Carrillo Lizbeth, Cebrián Mariano |
| Differential involvement of germline pathogenic variants in breast cancer genes between DCIS and low-grade invasive cancers. Journal of medical genetics 2022 11 . Evans D Gareth, Sithambaram Siva, van Veen Elke Maria, Burghel George J, Schlecht Helene, Harkness Elaine F, Byers Helen, Ellingford Jamie M, Gandhi Ashu, Howell Sacha J, Howell Anthony, Forde Claire, Lalloo Fiona, Newman William G, Smith Miriam Jane, Woodward Emma Rois |
| Cancer related mortality in multiple sclerosis. A population based cohort study. Multiple sclerosis and related disorders 2022 11 69 104417. Grytten Nina, Myhr Kjell-Morten, Celius Elisabeth G, Benjaminsen Espen, Midgard Rune, Vatne Anita, Aarseth Jan H, Mannseth Janne, Torkildsen Øivi |
| Remote AI Supported E-Multidisciplinary Oncology Conference in Breast Cancer as a Technology and Method to Optimize Outcomes in the Peripheries. Studies in health technology and informatics 2022 1 289 309-312. Mammas Constantinos S, Mamma Adamantia S, Papaxoinis George, Georgiou Ire |
| Integration of tumour sequencing and case-control data to assess pathogenicity of RAD51C missense variants in familial breast cancer. NPJ breast cancer 2022 1 8 (1): 10. Lim Belle W X, Li Na, Rowley Simone M, Thompson Ella R, McInerny Simone, Zethoven Magnus, Scott Rodney J, Devereux Lisa, Sloan Erica K, James Paul A, Campbell Ian |
| Pharmacogenetics and pharmacokinetics of tamoxifen in a Zimbabwean breast cancer cohort. British journal of clinical pharmacology 2023 6 . Bianza Tinotenda Mbavha, Roslyn Stella Thelingwani, Zedias Chikwambi, Anna Mary Nyakabau, Collen Masimirembwa, |
| Multiple sclerosis and breast cancer risk: a meta-analysis of observational and Mendelian randomization studies. Frontiers in neuroinformatics 2023 5 17 1154916. Tian Fang, Zhihao Zhang, Huijie Zhou, Wanchun Wu, Liqun Z |
| Clinical and Genotypic Insights Into Higher Prevalence of Palbociclib Associated Neutropenia in Asian Patients. The oncologist 2023 11 . Jiun-I Lai, Ting-Hao Kuo, Kuan-Jung Huang, Laura Min Xuan Chai, Mei-Hsuan Lee, Chun-Yu Liu, Yi-Fang Tsai, Chi-Cheng Huang, Ling-Ming Tseng, Cheng-Chih Hsu, Ta-Chung Ch |
| Exploring pharmacokinetic variability of palbociclib in HR+/HER2- metastatic breast cancer: a focus on age, renal function, and drug-gene interactions. Frontiers in pharmacology 2024 9 15 1420174. Elena Peruzzi, Bianca Posocco, Lorenzo Gerratana, Margherita Nuti, Marco Orleni, Sara Gagno, Elena De Mattia, Fabio Puglisi, Erika Cecchin, Giuseppe Toffoli, Rossana Ronca |
| Effect of Genetic Polymorphisms of ABCB1, ABCG2, and SLC22A1 on the Steady-State Plasma Concentrations of Lamotrigine in Treatment-Resistant Depressed Patients Treated With Lamotrigine Augmentation Therapy. Clinical neuropharmacology 2024 8 . Yoko Tomori, Takeshi Suzuki, Kazuo Mihara, Goyo Nagai, Shoko Kagawa, Akifumi Nakamura, Kenji Nemoto, Tsuyoshi Kon |
| Modification Effects of Homologous Recombination Repair Gene Polymorphisms on the Associations Between Urinary Metals and Breast Cancer Risk. Biological trace element research 2024 5 . Shushu Han, Minjie Lu, Yixin Zhang, Ying Lin, Qiang Liu, Lin Xu, Zefang R |
| Identification of non-adherence to adjuvant letrozole using a population pharmacokinetics approach in hormone receptor-positive breast cancer patients. European journal of pharmaceutical sciences : official journal of the European Federation for Pharmaceutical Sciences 2024 5 199 106809. Alicja Puszkiel, Florence Dalenc, Naïma Tafzi, Pierre Marquet, Marc Debled, William Jacot, Laurence Venat-Bouvet, Catherine Ferrer, Nadia Levasseur, Rodolphe Paulon, Jérôme Dauba, Alexandre Evrard, Vincent Mauriès, Thomas Filleron, Etienne Chatelut, Fabienne Thomas, Melanie White-Koni |
- Page last reviewed:Feb 1, 2024
- Content source: